--New positive preclinical studies show that sabizabulin can overcome drug resistance to daraxonrasi

MIAMI, FL, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopha

Veru Inc. (VERU) Q3 2026 Earnings Call Transcript

Veru (NASDAQ:VERU) reported quarterly losses of $(0.30) per share which beat the analyst consensus e

--  Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight

-- When issued U.S. patent protection until at least October 2044 -- -- Allowed patent adds to alrea

MIAMI, FL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

MIAMI, FL, July 30, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing inno

-- Phase 2b PLATEAU clinical trial exceeds targeted full enrollment of 200 patients — -- Interim ana

MIAMI, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

https://www.sec.gov/ix?doc=/Archives/edgar/data/863894/000143774926019478/veru20260601_8k.htm

Oppenheimer analyst Leland Gershell maintains Veru (NASDAQ:VERU) with a Outperform and lowers the

Veru Inc. (VERU) Q2 2026 Earnings Call Prepared Remarks Transcript

Veru (NASDAQ:VERU) reported quarterly losses of $(0.12) per share which beat the analyst consensus e

--Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on tr

MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharm

Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price crossed below its 200-day moving average du

Veru Inc. (NASDAQ: VERU - Get Free Report) shares passed below its 200-day moving average during tra

https://www.sec.gov/Archives/edgar/data/863894/000119312526145576/d84893ds3.htm

Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price passed below its 200-day moving average dur

-- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bo

Veru Inc. (VERU) Q1 2026 Earnings Call Transcript

Veru (NASDAQ: VERU - Get Free Report) and Flora Growth (NASDAQ: FLGC - Get Free Report) are both sma

MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

Veru Inc. (VERU) Q4 2025 Earnings Call Transcript

Investors are prepping for this week's earnings reports which include homebuilders, several appa

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly e

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company p

  On Wednesday, 311 stocks hit new 52-week lows.

  Friday's session saw 112 companies set new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings